Massachusetts Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23.7M | Buy |
|
|||||
|
2025
Q2 | $1.27M | Buy |
|
|||||
|
2025
Q1 | $963K | Sell |
|
|||||
|
2024
Q4 | $1.09M | Sell |
|
|||||
|
2024
Q3 | $939K | Sell |
|
|||||
|
2024
Q2 | $1.02M | Buy |
|
|||||
|
2024
Q1 | $1.12M | Sell |
|
|||||
|
2023
Q4 | $1.9M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $5.58M | Buy |
|
|||||
|
2017
Q4 | $5.48M | Buy |
|
|||||
|
2017
Q3 | $6.76M | Buy |
|
|||||
|
2017
Q2 | $4.98M | Sell |
|
|||||
|
2017
Q1 | $6.14M | Sell |
|
|||||
|
2016
Q4 | $5.16M | Sell |
|
|||||
|
2016
Q3 | $5.7M | Sell |
|
|||||
|
2016
Q2 | $7.75M | Buy |
|
|||||
|
2016
Q1 | $5.48M | Buy |
|